glutathione in the brain Glutathione transporter-mediated brain targeting prodrug

Topical cosmetic use is common and has a strong safety record, while injectable forms are compounded and remain under active FDA review

albicans filamentation 11

Lack of clinical evidence: Although there is encouraging preclinical research indicating the neuroprotective potential of phytochemicals in TBIs, the absence of comprehensive clinical data hinders the ability to substantiate their effectiveness and safety in human patients

This is also why injecting glutathione subcutaneously is the easiest means of administering the peptide in adequate doses, albeit multiple injections are required to achieve therapeutic levels of GSH support